Publication | Closed Access

Efficacy of a new oral agent (tocainide) in the acute treatment of refractory ventricular arrhythmias

Acute TreatmentHeart FailureCardiovascular DiseaseMedicineMyocardial InfarctionRefractory Ventricular ArrhythmiasCardiovascular PharmacologyPharmacotherapyNew Oral AgentPharmacologyCardiologyAnesthesiologyCardiac Arrest